Annual Gross Profit
$1.52 B
+$649.28 M+74.75%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual gross profit is currently $1.52 billion, with the most recent change of +$649.28 million (+74.75%) on 31 December 2023. During the last 3 years, it has risen by +$813.74 million (+115.57%). ALNY annual gross profit is now at all-time high.ALNY Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$415.01 M
-$176.14 M-29.80%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly gross profit is currently $415.01 million, with the most recent change of -$176.14 million (-29.80%) on 30 September 2024. Over the past year, it has increased by +$61.15 million (+17.28%). ALNY quarterly gross profit is now -37.71% below its all-time high of $666.22 million, reached on 30 September 2023.ALNY Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$1.79 B
-$251.21 M-12.32%
30 September 2024
Summary:
Alnylam Pharmaceuticals TTM gross profit is currently $1.79 billion, with the most recent change of -$251.21 million (-12.32%) on 30 September 2024. Over the past year, it has increased by +$270.50 million (+17.82%). ALNY TTM gross profit is now -12.32% below its all-time high of $2.04 billion, reached on 30 June 2024.ALNY TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +17.3% | +17.8% |
| 3 y3 years | +115.6% | +87.9% | +154.0% |
| 5 y5 years | +679.6% | +597.4% | +818.6% |
ALNY Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +115.6% | -37.7% | +133.6% | -12.3% | +154.0% |
| 5 y | 5 years | at high | +679.6% | -37.7% | +597.4% | -12.3% | +818.6% |
| alltime | all time | at high | +3118.7% | -37.7% | >+9999.0% | -12.3% | >+9999.0% |
Alnylam Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $415.01 M(-29.8%) | $1.79 B(-12.3%) |
| June 2024 | - | $591.15 M(+38.0%) | $2.04 B(+21.3%) |
| Mar 2024 | - | $428.36 M(+21.1%) | $1.68 B(+10.8%) |
| Dec 2023 | $1.52 B(+74.8%) | $353.86 M(-46.9%) | $1.52 B(+4.8%) |
| Sept 2023 | - | $666.22 M(+185.5%) | $1.45 B(+44.1%) |
| June 2023 | - | $233.38 M(-11.7%) | $1.00 B(+5.2%) |
| Mar 2023 | - | $264.42 M(-6.8%) | $955.39 M(+10.0%) |
| Dec 2022 | $868.60 M(+23.4%) | $283.77 M(+27.1%) | $868.60 M(+7.8%) |
| Sept 2022 | - | $223.19 M(+21.3%) | $805.70 M(+9.3%) |
| June 2022 | - | $184.01 M(+3.6%) | $737.48 M(+0.3%) |
| Mar 2022 | - | $177.63 M(-19.6%) | $735.27 M(+4.4%) |
| Dec 2021 | $704.14 M(+69.8%) | $220.87 M(+42.5%) | $704.14 M(+12.9%) |
| Sept 2021 | - | $154.97 M(-14.8%) | $623.81 M(+8.9%) |
| June 2021 | - | $181.80 M(+24.1%) | $572.90 M(+20.6%) |
| Mar 2021 | - | $146.50 M(+4.2%) | $475.13 M(+14.5%) |
| Dec 2020 | $414.80 M(+113.1%) | $140.54 M(+35.1%) | $414.80 M(+24.3%) |
| Sept 2020 | - | $104.06 M(+23.8%) | $333.77 M(+13.3%) |
| June 2020 | - | $84.03 M(-2.5%) | $294.56 M(+17.4%) |
| Mar 2020 | - | $86.17 M(+44.8%) | $250.91 M(+28.9%) |
| Dec 2019 | $194.69 M | $59.51 M(-8.2%) | $194.69 M(+26.0%) |
| Sept 2019 | - | $64.85 M(+60.6%) | $154.55 M(+68.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $40.39 M(+34.9%) | $91.64 M(+12.9%) |
| Mar 2019 | - | $29.95 M(+54.6%) | $81.15 M(+11.0%) |
| Dec 2018 | $73.11 M(-18.7%) | $19.37 M(+902.5%) | $73.11 M(-20.2%) |
| Sept 2018 | - | $1.93 M(-93.5%) | $91.66 M(-14.2%) |
| June 2018 | - | $29.91 M(+36.6%) | $106.83 M(+38.9%) |
| Mar 2018 | - | $21.90 M(-42.3%) | $76.92 M(+39.8%) |
| Dec 2017 | $89.91 M(+90.7%) | $37.92 M(+121.8%) | $55.02 M(+221.8%) |
| Sept 2017 | - | $17.10 M(-17.8%) | $17.10 M(-72.6%) |
| Dec 2016 | $47.16 M(-53.1%) | - | - |
| Sept 2011 | - | $20.79 M(+0.9%) | $62.30 M(-9.9%) |
| June 2011 | - | $20.61 M(-1.4%) | $69.18 M(-8.0%) |
| Mar 2011 | - | $20.90 M(-24.5%) | $75.18 M(-28.7%) |
| Sept 2010 | - | $27.67 M(+3.9%) | $105.47 M(+3.4%) |
| June 2010 | - | $26.62 M(+8.4%) | $102.06 M(+2.0%) |
| Mar 2010 | - | $24.56 M(-7.7%) | $100.04 M(-0.5%) |
| Dec 2009 | $100.53 M(+4.5%) | $26.63 M(+9.8%) | $100.53 M(+36.0%) |
| Sept 2009 | - | $24.25 M(-1.4%) | $73.91 M(+48.8%) |
| June 2009 | - | $24.60 M(-1.8%) | $49.66 M(+98.2%) |
| Mar 2009 | - | $25.06 M | $25.06 M |
| Dec 2008 | $96.16 M(+88.9%) | - | - |
| Dec 2007 | $50.90 M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly gross profit year-on-year change?
- What is Alnylam Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM gross profit year-on-year change?
What is Alnylam Pharmaceuticals annual gross profit?
The current annual gross profit of ALNY is $1.52 B
What is the all time high annual gross profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual gross profit is $1.52 B
What is Alnylam Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of ALNY is $415.01 M
What is the all time high quarterly gross profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly gross profit is $666.22 M
What is Alnylam Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, ALNY quarterly gross profit has changed by +$61.15 M (+17.28%)
What is Alnylam Pharmaceuticals TTM gross profit?
The current TTM gross profit of ALNY is $1.79 B
What is the all time high TTM gross profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM gross profit is $2.04 B
What is Alnylam Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, ALNY TTM gross profit has changed by +$270.50 M (+17.82%)